Effect of atenolol on birth weight

American Journal of Cardiology

Volumn 79, Issue 10, 1997, Pages 1436-1438

  Lip, Gregory Y H ^a   Beevers, Michèle ^b   Churchill, David ^b   Shaffer, Lara M ^b   Beevers, D Gareth ^b  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; LABETALOL; METHYLDOPA;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; INFANT; INTRAUTERINE GROWTH RETARDATION; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; NEWBORN; PLACENTA WEIGHT; PREGNANCY COMPLICATION; PRIORITY JOURNAL;

ANALYSIS OF VARIANCE; ANTHROPOMETRY; ANTIHYPERTENSIVE AGENTS; ATENOLOL; BIRTH WEIGHT; FEMALE; FETAL GROWTH RETARDATION; GESTATIONAL AGE; HUMANS; HYPERTENSION; ORGAN SIZE; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PROSPECTIVE STUDIES; REGRESSION ANALYSIS;

EID: 0030966822     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)00163-X     Document Type: Article

References (12)

1. Butters L, Kennedy S, Rubin PC. Atenolol in essential hypertension during pregnancy. Br Med J 1990;301:587-589.
2. Kyle PM, Redman CW. Comparative risk-benefit assessment of drugs used in the management of hypertension in pregnancy. Drug Saf 1992;7:223-234.
3. de Grauw TJ, Hopkins B. Severity of growth retardation and physical condition at birth in small for gestational age infants. Biol Neonate 1991;60:176-183.
4. Fay RA, Dey PL, Saadie CM, Buhl JA, Gebski VJ. Ponderal index: a better definition of the "at risk" group with intrauterine growth problems than birth weight for gestational age in term infants. Aust N Z J Obstet Gynaecol 1991;31:17-19.
5. Rubin PC. Beta-blockers in pregnancy. N Engl J Med 1981;305:1323-1326.
6. Rubin PC, Butters L, Low RA, Reid JL. Atenolol in the treatment of essential hypertension during pregnancy. Br J Clin Pharmacol 1982;14:279-281.
7. Rubin PC, Butters L, Clark DM, Reynolds B, Sumner DJ, Steedman D, Low RA, Reid JL. Placebo-controlled trial of atenolol in treatment of pregnancy-associated hypertension. Lancet 1983;2:431-434.
8. Fidler J, Smith V, Fayers P, De Swiet M. Randomised controlled comparative study of methyldopa and oxprenolol in treatment of hypertension in pregnancy. Br Med J 1983;286:1927-1930.
9. Wichman K, Ryulden G, Karlberg BE, A placebo controlled trial of metoprolol in the treatment of hypertension in pregnancy. Scand J Clin Lab Invest 1984;169:90-94.
10. Montan S, Ingemarsson I, Marsal K, Sjoberg NO. Randomised controlled trial of atenolol and pindolol in human pregnancy: effects on fetal haemodynamics. Br Med J 1992;304:946-949.
11. Constantine G, Beevers DG, Reynolds AL, Luesley DM. Nifedipine as a second-line antihypertensive drug in pregnancy. Br J Obst Gynaecol 1987;94:1136-1142.
12. Rubin PC, Butters L, Clark D, Sumner D, Selfield A, Pledger D, Low RA, Reid JL. Obstetric aspects of the use in pregnancy-associated hypertension of the beta-adrenoceptor antagonist atenolol. Am J Obstet Gynecol 1984;150:389-392.